nearly significantP=0.058
However, when we analyzed the impact of MCS in patients with advanced SCAI stages (D and E), a nearly significant benefit was observed (HR, 0.45; 95% CI, 0.19–1.06; log-rank test P=0.058) ( Figure 4 ).
However, when we analyzed the impact of MCS in patients with advanced SCAI stages (D and E), a nearly significant benefit was observed (HR, 0.45; 95% CI, 0.19–1.06; log-rank test P=0.058) ( Figure 4 ).